Quick Answer
BeOne Medicines Ltd. reported Total Revenue of $5.34 billion for the year ending 2025.
- BeOne Medicines Ltd. showed an increase of +40.2% in Total Revenue from 2024 to 2025.
- This data is from BeOne Medicines Ltd.'s annual report (Form 10-K), filed with the SEC on February 26, 2026.
- XBRL data for this metric is available from 2014 to 2025 (14 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2015: $1.38 million | Q2 2015: $1.38 million | Q3 2015: $1.38 million | Q4 2015: $4.68 million | Q1 2016: $677.0 thousand | Q2 2016: $393.0 thousand | Q1 2017: $0.00 | Q2 2017: $0.00 | Q2 2017: $0.00 | Q3 2017: $220.21 million | Q3 2017: $220.21 million | Q4 2017: $18.17 million | Q4 2017: $18.17 million | Q1 2018: $32.54 million | Q1 2018: $32.54 million | Q2 2018: $52.80 million | Q2 2018: $52.80 million | Q3 2018: $54.20 million | Q3 2018: $54.20 million | Q4 2018: $58.67 million | Q1 2019: $77.83 million | Q2 2019: $243.35 million | Q3 2019: $50.14 million | Q4 2019: $56.89 million | Q1 2020: $52.06 million | Q2 2020: $65.64 million | Q3 2020: $91.08 million | Q4 2020: $100.10 million | Q1 2021: $605.87 million | Q2 2021: $149.99 million | Q3 2021: $206.44 million | Q1 2022: $306.63 million | Q2 2022: $341.57 million | Q3 2022: $387.63 million | Q1 2023: $447.80 million | Q2 2023: $595.26 million | Q3 2023: $781.31 million | Q1 2024: $751.65 million | Q2 2024: $929.17 million | Q3 2024: $1.00 billion | Q1 2025: $1.12 billion | Q2 2025: $1.32 billion | Q3 2025: $1.41 billion.
- Over the full 14 years of available data (2014 to 2025), BeOne Medicines Ltd.'s Total Revenue has grown by 40,889.9%.
- Historical annual values: Fiscal year 2025: $5.34 billion | Fiscal year 2024: $3.81 billion | Fiscal year 2023: $2.46 billion | Fiscal year 2022: $1.42 billion | Fiscal year 2021: $1.18 billion | Fiscal year 2020: $308.87 million | Fiscal year 2019: $428.21 million | Fiscal year 2018: $198.22 million | Fiscal year 2017: $238.39 million | Fiscal year 2017: $238.39 million | Fiscal year 2016: $1.07 million | Fiscal year 2016: $1.07 million | Fiscal year 2015: $8.82 million | Fiscal year 2014: $13.04 million.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: